ANDREW DANG: Open Payments
NPI 1063192953 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,548 in 49 payments from 5 companies in 2025. Trend: 2023 $224 · 2024 $618 · 2025 $1,548
Food & beverage: $1,439Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 43 | $1,289 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 2 | $62 |
| Alkermes, Inc. | 2 | $53 |
| Luye Pharma (USA) Ltd. | 1 | $19 |
Products named: UZEDY, CAPLYTA, COBENFY, ARISTADA, ERZOFRI EXTENDED-RELEASE.
Industry payments across CA — which companies pay providers there.
